A Non-interventional, Multi-centre Study to Investigate the Change in Patient-reported Outcomes in Moderate to Severe COPD Patients Newly Initiated on TRIXEO AEROSPHERE (Budesonide/Glycopyrronium/Formoterol) in Real-life Setting in Romania
Latest Information Update: 26 Dec 2025
At a glance
- Drugs Budesonide/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms COnCORD
- Sponsors AstraZeneca
Most Recent Events
- 22 Dec 2025 Status changed from active, no longer recruiting to completed.
- 11 Sep 2025 Planned End Date changed from 30 Sep 2025 to 30 Nov 2025.
- 11 Sep 2025 Planned primary completion date changed from 30 Sep 2025 to 30 Nov 2025.